NCT05356702 · ACTIVE NOT RECRUITING
The Brain Health Study: A Pragmatic, Patient-Centered Trial
This trial is testing a screening tool called eRADAR, which uses existing electronic health records to flag patients in primary care who may have undetected dementia. The goal is to see whether this low-cost approach helps doctors identify dementia earlier. This is a Phase NA pragmatic trial, meaning it is testing a real-world process rather than a drug or device, in everyday clinical settings.
Eligibility criteria
Inclusion Criteria: * No prior diagnosis of dementia (defined from EHR diagnosis codes) and not receiving medications for dementia * Active patient at participating clinic * Adequate data to calculate eRADAR score Exclusion Criteria: - Currently receiving hospice care
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-04-06